People news

Share this article:

Sudler & Hennessey (S&H) New York has announced the promotion of Rod Boyd and Diane Ohye to joint executive creative directors. As executive creative directors, Boyd and Ohye will be jointly responsible for the New York-based creative team, reporting to Rob Rogers, chief creative officer. Ohye joined S&H in 1988 as a senior copywriter, and after a brief three-year hiatus in 2002, she returned to S&H in 2005 as SVP, creative strategy director. Meanwhile, after spending the last 12 of his many years in healthcare advertising at S&H, Boyd has seen the S&H creative department grow from a staff of less than 20 writers and art directors to a department of over 80.

Euro RSCG Worldwide PR named Douglas Stroup EVP. Stroup joins from Ruder Finn, where he worked on the agency's branding practice, and previously worked at Nelson Communications. He reports to Chantal Beaudry, EVP, managing director.

Pacific Communications has hired Mark Davey as art supervisor in the agency's creative department. In his new role, Davey will be responsible for art direction on Juvederm and other dermal fillers made and marketed by Allergan. Before joining Pacific Communications, Davey built a career in New York City, contributing his talents to agencies such as Euro RSCG, Draftfcb and Young & Rubicam.

Interactive medical information service company Informed Medical Communications (IMC) named Charles Saldarini to its board of directors. The announcement was issued by IMC CEO, Steven K. Budd, from the company's headquarters in New York City. Saldarini brings to IMC an extensive history of entrepreneurial innovation in the area of healthcare services, most recently as a driving force behind New Jersey-based provider of outsourced sales and marketing solutions to the pharma industry, PDI. During his 18-year tenure with the company.

Share this article:

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

AstraZeneca takes on pediatricians

The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.

UK generic use soared in 2013

Generics made up almost 75% of prescriptions in the United Kingdom last year.

GSK refutes consumer spin-off rumor

The company refutes a Financial Times rumor that one was happening soonish.